Search
Cystic fibrosis transmembrane conductance regulator
go.drugbank.com/drugs/DB15180InvestigationalCystic fibrosis transmembrane conductance regulator is under investigation in clinical trial NCT00004806 (Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis).
Categories: ATP-Binding Cassette, Sub-Family C ProteinsDubermatinib
go.drugbank.com/drugs/DB15187InvestigationalDubermatinib is under investigation in clinical trial NCT03572634 (Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL).
Categories: Heterocyclic Compounds, 1-RingLysergic acid 2,4-dimethylazetidide
go.drugbank.com/drugs/DB15196ExperimentalLysergic acid 2,4-dimethylazetidide is under investigation in clinical trial NCT02765802 (A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection
Ciraparantag
go.drugbank.com/drugs/DB15199InvestigationalCiraparantag is under investigation in clinical trial NCT01826266 (Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban).
Categories: Heterocyclic Compounds, 1-RingJNJ-26489112
go.drugbank.com/drugs/DB15203InvestigationalJNJ-26489112 is under investigation in clinical trial NCT00579384 (A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive
Categories: Heterocyclic Compounds, 1-RingPemafibrate
go.drugbank.com/drugs/DB15212InvestigationalPemafibrate is under investigation in clinical trial NCT03350165 (A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)).
Synonyms: K-877Categories: Heterocyclic Compounds, 2-Ring25-desacetylrifapentine
go.drugbank.com/drugs/DB15213Investigational25-desacetylrifapentine is under investigation in clinical trial NCT00023387 (TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine).
Categories: Heterocyclic Compounds with 4 or More RingsPF-06260414
go.drugbank.com/drugs/DB15221InvestigationalPF-06260414 is under investigation in clinical trial NCT02070939 (Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects).
Categories: Heterocyclic Compounds, 2-RingFlotetuzumab
go.drugbank.com/drugs/DB15223InvestigationalFlotetuzumab is under investigation in clinical trial NCT02152956 (Safety Study of MGD006 in Relapsed/Refractory Acute Myeloid Leukemia (AML) or Intermediate-2/High Risk MDS).
Lisavanbulin
go.drugbank.com/drugs/DB15224InvestigationalLisavanbulin is under investigation in clinical trial NCT02895360 (Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma).
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring